4D Molecular Therapeutics Inc Change of Control Agreements
7 Contracts & Agreements
- Amended and Restated Change in Control and Severance Agreement, dated June 23, 2023 by and between Robert Kim and the Registrant (Filed With SEC on February 29, 2024)
- Change in Control and Severance Agreement, dated September 22, 2021, by and between Scott Bizily and the Registrant (Filed With SEC on February 29, 2024)
- Change in Control and Severance Agreement, dated August 29, 2023, by and between Uneek Mehra and the Registrant (Filed With SEC on February 29, 2024)
- Change in Control and Severance Agreement, dated September 22, 2021, by and between Fred Kamal and 4D Molecular Therapeutics, Inc (Filed With SEC on November 10, 2021)
- Change in Control and Severance Agreement, dated September 22, 2021, by and between Robert Stephen Fishman and 4D Molecular Therapeutics, Inc (Filed With SEC on September 24, 2021)
- Change in Control and Severance Agreement, dated September 22, 2021, by and between August Moretti and 4D Molecular Therapeutics, Inc (Filed With SEC on September 24, 2021)
- Change in Control and Severance Agreement, dated September 22, 2021, by and between David Kirn and 4D Molecular Therapeutics, Inc (Filed With SEC on September 24, 2021)
